Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-035084)

Filing Details

Accession Number:: 0001209191-10-035084
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-06-21 13:00:00
Reporting Period:: 2010-06-17

Filing Date:: 2010-06-21
Accepted Time:: 2010-06-21 13:56:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
949858	Oncogenex Pharmaceuticals Inc.	OGXI	In Vitro & In Vivo Diagnostic Substances (2835)	954343413

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1238250	A Michael Martino	1522 217Th Pl Se, Suite 100 Bothell WA 98021		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-06-17	1,073	$6.66	12,073	No	4	M	Direct
Common Stock	Acquisiton	2010-06-17	3,760	$7.25	15,833	No	4	M	Direct
Common Stock	Disposition	2010-06-17	4,833	$0.00	11,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	stock option (right to buy)	Disposition	2010-06-17	1,073	$0.00	1,073	$6.66
Common Stock	Stock option (right to buy)	Disposition	2010-06-17	3,760	$0.00	3,760	$7.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2008-03-18	2018-03-18	No	4	M	Direct
4,500	2009-05-12	2016-05-12	No	4	M	Direct

Footnotes

This is the weighted average price. The prices ranged from $14.00 to $14.25. The reporting person undertakes to provide on request a detailed breakout of the pricing.